ABSTRACT
We present AAI-profiler, a web server for exploratory analysis and quality control in comparative genomics. AAI-profiler summarizes proteome-wide sequence search results to identify novel species, assess the need for taxonomic reclassification and detect multi-isolate and contaminated samples. AAI-profiler visualises results using a scatterplot that shows the Average Amino-acid Identity (AAI) from the query proteome to all similar species in the sequence database. Taxonomic groups are indicated by colour and marker styles, making outliers easy to spot. AAI-profiler uses SANSparallel to perform high-performance homology searches, making proteome-wide analysis possible. We demonstrate the efficacy of AAI-profiler in the discovery of a close relationship between two bacterial symbionts of an omnivorous pirate bug (Orius) and a thrip (Frankliniella occidentalis), an important pest in agriculture. The symbionts represent novel species within the genus Rosenbergiella so far described only in floral nectar. AAI-profiler is easy to use, the analysis presented only required two mouse clicks and was completed in a few minutes. AAI-profiler is available at http://ekhidna2.biocenter.helsinki.fi/AAI.
Subject(s)
Bacterial Proteins/genetics , Chlamydia trachomatis/classification , Erwinia/classification , Phylogeny , Proteome/genetics , Software , Amino Acid Sequence , Animals , Bacterial Proteins/classification , Bacterial Proteins/metabolism , Chlamydia trachomatis/genetics , Chlamydia trachomatis/isolation & purification , Erwinia/genetics , Erwinia/isolation & purification , Gene Expression , Genomics/methods , Heteroptera/microbiology , Internet , Molecular Sequence Annotation , Proteome/classification , Proteome/metabolism , Sequence Homology, Amino Acid , Symbiosis/physiology , Thysanoptera/microbiologyABSTRACT
The M-type receptor for phospholipase A2 (PLA2R1) is the major target antigen in idiopathic membranous nephropathy (iMN). Our recent genome-wide association study showed that genetic variants in an HLA-DQA1 and phospholipase A2 receptor (PLA2R1) allele associate most significantly with biopsy-proven iMN, suggesting that rare genetic variants within the coding region of the PLA2R1 gene may contribute to antibody formation. Here, we sequenced PLA2R1 in a cohort of 95 white patients with biopsy-proven iMN and assessed all 30 exons of PLA2R1, including canonical (GT-AG) splice sites, by Sanger sequencing. Sixty patients had anti-PLA2R1 in serum or detectable PLA2R1 antigen in kidney tissue. We identified 18 sequence variants, comprising 2 not previously described, 7 reported as rare variants (<1%) in the Single Nucleotide Polymorphism Database or the 1000 Genomes project, and 9 known to be common polymorphisms. Although we confirmed significant associations among 6 of the identified common variants and iMN, only 9 patients had the private or rare variants, and only 4 of these patients were among the 60 who were PLA2R positive. In conclusion, rare variants in the coding sequence of PLA2R1, including splice sites, are unlikely to explain the pathogenesis of iMN.
Subject(s)
Glomerulonephritis, Membranous/genetics , Receptors, Phospholipase A2/genetics , Adult , Aged , Female , Genetic Predisposition to Disease , Genomic Structural Variation , Humans , Male , Middle Aged , Polymorphism, Single Nucleotide , Sequence Analysis, DNAABSTRACT
Dystonia type 4 (DYT4) was first described in a large family from Heacham in Norfolk with an autosomal dominantly inherited whispering dysphonia, generalized dystonia, and a characteristic hobby horse ataxic gait. We carried out a genetic linkage analysis in the extended DYT4 family that spanned 7 generations from England and Australia, revealing a single LOD score peak of 6.33 on chromosome 19p13.12-13. Exome sequencing in 2 cousins identified a single cosegregating mutation (p.R2G) in the ß-tubulin 4a (TUBB4a) gene that was absent in a large number of controls. The mutation is highly conserved in the ß-tubulin autoregulatory MREI (methionine-arginine-glutamic acid-isoleucine) domain, highly expressed in the central nervous system, and extensive in vitro work has previously demonstrated that substitutions at residue 2, specifically R2G, disrupt the autoregulatory capability of the wild-type ß-tubulin peptide, affirming the role of the cytoskeleton in dystonia pathogenesis.
Subject(s)
Dystonic Disorders/genetics , Genetic Predisposition to Disease/genetics , Mutation/genetics , Tubulin/genetics , Adult , Animals , Australia , Brain/pathology , Dystonic Disorders/pathology , England , Exome , Female , Genetic Linkage , Genotype , Humans , Male , Middle Aged , Pedigree , Polymorphism, Single Nucleotide/geneticsABSTRACT
BACKGROUND/AIMS: Calcium homeostasis requires regulated cellular and interstitial systems interacting to modulate the activity and movement of this ion. Disruption of these systems in the kidney results in nephrocalcinosis and nephrolithiasis, important medical problems whose pathogenesis is incompletely understood. METHODS: We investigated 25 patients from 16 families with unexplained nephrocalcinosis and characteristic dental defects (amelogenesis imperfecta, gingival hyperplasia, impaired tooth eruption). To identify the causative gene, we performed genome-wide linkage analysis, exome capture, next-generation sequencing, and Sanger sequencing. RESULTS: All patients had bi-allelic FAM20A mutations segregating with the disease; 20 different mutations were identified. CONCLUSIONS: This autosomal recessive disorder, also known as enamel renal syndrome, of FAM20A causes nephrocalcinosis and amelogenesis imperfecta. We speculate that all individuals with biallelic FAM20A mutations will eventually show nephrocalcinosis.
Subject(s)
Amelogenesis Imperfecta/genetics , Dental Enamel Proteins/genetics , Genetic Predisposition to Disease/genetics , Mutation , Nephrocalcinosis/genetics , Adolescent , Adult , Amelogenesis Imperfecta/complications , Amelogenesis Imperfecta/pathology , Child , Consanguinity , Exome/genetics , Family Health , Female , Genes, Recessive/genetics , Genome-Wide Association Study , Humans , Male , Middle Aged , Nephrocalcinosis/complications , Nephrocalcinosis/pathology , Pedigree , Sequence Analysis, DNA/methods , Syndrome , Young AdultABSTRACT
A revolution is happening in genetics! The decoding of the first genome in 2003 was a large international collaborative effort that took about 13 years at a cost of around $2.7 billion. Now, only a few years later, new technology allows the sequencing of an entire genome within a few weeks--and at a cost of less than $10,000. The vaunted $1000 genome is within reach. These extraordinary advances will undoubtedly transform the way we practice medicine. But, like any new technology, it carries risks, as well as benefits. As physicians, we need to understand the implications in order to best utilise these advances for our patients and to provide informed advice. In this review, our aim is to explain these new technologies, to separate the hype from the reality and to address some of the resulting questions and implications. The practical objective is to provide a simple overview of the available technologies and of purpose to which they are best suited.